Use of liposomal glucocorticoids for treating inflammatory states
US7744920B2 · kind B2 · utility
3Cited by
0References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 11, 2005 |
| Grant date | Jun 29, 2010 |
| Priority date | — |
| Expiry date | Mar 31, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides the use of a glucocorticoid (GC) or of a GC derivative encapsulated in a liposome for the preparation of a pharmaceutical composition for the treatment of an inflammatory associated condition in a subject, provided that said condition is not associated with a neurodegenerative disease or disorder. A specific use concerns a liposomal formulation comprising methylprednisolone sodium hemisuccinate (MPS) for the treatment of rheumatoid arthritis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.